Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)

18.59
Delayed Data
As of Jan 18
 -1.12 / -5.68%
Today’s Change
9.72
Today|||52-Week Range
33.97
-18.71%
Year-to-Date
Biogen Is More Likely to Be a Buyer Than Seller
Jan 14 / GuruFocus News - Paid Partner Content
My 3 Top Biopharma Stock Picks for 2022
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close19.71
Today’s open18.90
Day’s range18.56 - 19.89
Volume79,750
Average volume (3 months)4,372,952
Market cap$2.6B
Data as of 4:28pm ET, 01/18/2022

Growth & Valuation

Earnings growth (last year)+34.90%
Earnings growth (this year)+21.78%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,660.38%
P/E ratioNM
Price/Sales32.69
Price/Book6.13

Competitors

 Today’s
change
Today’s
% change
RCUSArcus Biosciences In...-1.51-4.22%
IBRXImmunitybio Inc-0.44-6.60%
IOVAIovance Biotherapeut...-1.04-6.71%
----
Data as of 4:01pm ET, 01/18/2022

Financials

Next reporting dateMarch 18, 2022
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$50.1M
Annual profit (last year)-$102.7M
Net profit margin-204.88%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts